A major analysis led by the Centro Nacional de Investigaciones Cardiovasculares (CNIC), in collaboration with international institutions, has pooled data from 17,801 myocardial infarction survivors ...
A new study published on the preprint server medRxiv* finds improved Fc cross-reactivity against certain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern (VOCs).
The findings confirm the results of the CNIC-led REBOOT clinical trial and consolidate a paradigm shift in infarction treatment. A major analysis led by the Centro Nacional de Investigaciones ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback